“… Change scores correlated high with WOMAC physical function | | Hypothesis that change scores of measures intended for a similar purpose should display moderate correlation. No hypothesis for SRM on expected magnitude of effect size | Yes, moderate (borderline high) correlations | In publication responsiveness is called ‘longitudinal convergent construct validity’ | Adequate (properties WOMAC for present population not reported in text) | Enemark Larsen [ 20 ] | Construct approach comparator and subgroups, comparison of delta COPM with delta WHO-5, EQ VAS (using Spearman correlations), and in subgroups of AQ with self-rated change, and in subgroups with cut-points WHO-5 and EQ VAS (using ROC curves) | Rehabilitation for various reasons; follow-up assessment after mean 101 days (SD 59.1; range 7–288) | Correlations of change scores of COPM-P and -S with WHO-5 0.22 and 0.32, with EQ VAS 0.32 and 0.36; Mean change scores COPM-P 3.1 (SD 2.8), COPM-S 3.0 (SD 1.8); changes higher in better subgroups for AQ/sharp (AUC 0.86/0.76 for P and 0.85/0.75 for S), for WHO-5 only the higher end, for EQ VAS only the lower end with COPM-P (AUCs < 0.70) | Change scores correlated low with WHO-5 and EQ VAS; mean changes higher in better subgroups AQ (AUC > 0.70) | Change scores correlated low with WHO-5 and EQ VAS; mean changes higher in better subgroups AQ (AUC > 0.70) | Hypotheses formulated based on anchor question self-rated change, and based on clinically relevant cut-points for comparator scales | Partly, COPM responsive to change compared to patient-reported improvement, but not so much with WHO-5 or EQ VAS | COPM-sumscores not limited to similar OPIs across both time points; MIC recommendations | C: adequate/s: doubtful (no description of important characteristics subgroups) |
Kjeken [ 22 ] | Construct approach intervention with comparators; analyses of change scores for COPM using paired sample t test, and comparison of standardized response means (SRM) with other instruments MHAQ WOMAC AUSCAN | OT intervention (depending on intake), follow-up 4 months after baseline | Mean change scores COPM-P −1.51 (CI −2.04; −0.98), COPM-S −2.22 (CI −2.80; −1.63); SRM large for COPM-P (0.7) and COPM-S (0.9), moderate for MHAQ (0.5), and small for WOMAC (0.15) and AUSCAN (0.25) | Scores changed significantly; SRM higher than for other measures MHAQ, WOMAC, AUSCAN | Scores changed significantly; SRM higher than for other measures MHAQ, WOMAC, AUSCAN | No hypotheses regarding treatment effect | N/A | | Doubtful (patients who changed medication or undergone surgica... |
…”